Jingying Xu Kite Pharma

Jingying Xu is a seasoned regulatory affairs leader with over 15 years of experience advancing cell and gene therapy (CGT) products globally. A formally trained scientist with deep expertise in immunotherapy and translational research, she integrates scientific rigor with forward looking, risk based regulatory pathways to guide programs from bench to IND and toward approval.